SOLNATIDE, the therapeutic molecule solnatide developed by APEPTICO for the treatment of various forms of life-threatening...Read More
The spread of Coronavirus continues both in Italy and globally.
For this reason, in order to protect the...Read More
Meet one of our delegates at one of the conferences below and find out how OPIS can assist you in your clinical drug development programmes.
See you in Munich on the 5th and the 6th of February at the Outsourcing in Clinical Trials Medical Devices Europe...Read More
Important topics will be discussed at Cell Therapy Manufacturing & Gene Therapy Congress, Amsterdam, 3 - 6 December...Read More